Glue ablation of a late-presentation urinary fistula after partial nephrectomy

Autor: J J Aning, M A Stott, A F Watkinson

Urinary fistula is an acknowledged complication of partial nephrectomy. We describe a case of a urinary fistula that failed to respond to conventional treatment and the subsequent use of percutaneous Hystoacryl® glue to achieve its resolution.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84db4abdd600b9afa47dcbeabab0bddb
https://europepmc.org/articles/PMC3473387/

Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].

Autor: Mir MC; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; Fundacion Instituto Valenciano Oncologia, Valencia, Spain. Electronic address: mirmare@yahoo.es., Marchioni M; Departmentof Medical, Oral and Biotechnological Sciences, Urology Unit, University 'G. d'Annunzio', Chieti-Pescara, Italy., Zargar H; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada., Zargar-Shoshtari K; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fairey AS; University of Alberta, Edmonton, Alberta, Canada., Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Dinney CP; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Krabbe LM; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Urology, University of Münster, Münster, Germany., Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, OK, USA., Jacobsen NE; University of Alberta, Edmonton, Alberta, Canada., Griffin J; Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA., Montgomery JS; Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA., Vasdev N; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK., Yu EY; Department of Medicine, Division of Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Xylinas E; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, USA; Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France., McGrath JS; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK., Kassouf W; Department of Surgery (Division of Urology), McGill University Health Center, Montreal, Canada., Dall'Era MA; Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, CA, USA., Sridhar SS; Princess Margaret Hospital, Toronto, Ontario, Canada., Aning J; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK., Shariat SF; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, USA; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; UT Southwestern, Dallas, TX, USA; Charles University, Prag, Czech Republic; University of Jordan, Amman, Jordan., Wright JL; Department of Urology, University of Washington, Seattle, WA, USA., Thorpe AC; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK., Morgan TM; Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA., Holzbeierlein JM; Department of Urology, University of Kansas Medical Center, Kansas City, KS, USA., Bivalacqua TJ; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins School of Medicine, Baltimore, MD, USA., North S; Cross Cancer Institute, Edmonton, AB, Canada; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Barocas DA; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Grivas P; Department of Medicine, Division of Oncology, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Stephenson AJ; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Urology, RUSH University, Chicago, IL, USA., Shah JB; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA., van Rhijn BW; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Daneshmand S; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, USA., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

Publikováno v: European urology focus [Eur Urol Focus] 2022 Sep; Vol. 8 (5), pp. 1559. Date of Electronic Publication: 2022 Feb 15.

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.

Autor: Vasdev N; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, SG1 4AB, UK. nikhil.vasdev@nhs.net.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK. nikhil.vasdev@nhs.net.; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK. nikhil.vasdev@nhs.net., Zargar H; Department of Urology, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia.; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Noël JP; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, SG1 4AB, UK.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK., Veeratterapillay R; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK., Fairey AS; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, USA.; University of Alberta, Edmonton, AB, Canada., Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Dinney CP; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., Mir MC; Department of Urology, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia., Krabbe LM; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Cookson MS; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, OK, USA., Jacobsen NE; University of Alberta, Edmonton, AB, Canada., Gandhi NM; Department of Urology, The Johns Hopkins School of Medicine, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Griffin J; Department of Urology, Medical Center, University of Kansas, Kansas City, KS, USA., Montgomery JS; Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA., Yu EY; Division of Oncology, Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Xylinas E; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, USA., Campain NJ; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK., Kassouf W; (Division of Urology) Department of Surgery, McGill University Health Center, Montreal, QC, Canada., Dall'Era MA; Department of Urology, Davis Medical Center, University of California at Davis, Sacramento, CA, USA., Seah JA; Princess Margaret Cancer Center, Toronto, ON, Canada., Ercole CE; Department of Urology, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia., Horenblas S; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Sridhar SS; Princess Margaret Cancer Center, Toronto, ON, Canada., McGrath JS; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK., Aning J; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK.; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, UK., Shariat SF; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, NY, USA.; Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria., Wright JL; Division of Oncology, Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Morgan TM; Department of Urology, University of Michigan Health System, Ann Arbor, MI, USA., Bivalacqua TJ; Department of Urology, The Johns Hopkins School of Medicine, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., North S; Cross Cancer Institute, Edmonton, AB, Canada., Barocas DA; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Grivas P; Division of Oncology, Department of Medicine, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Stephenson AJ; Department of Urology, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia., Shah JB; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA., van Rhijn BW; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Daneshmand S; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA, USA., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Holzbeierlein JM; Department of Urology, Medical Center, University of Kansas, Kansas City, KS, USA., Thorpe A; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK., Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Publikováno v: World journal of urology [World J Urol] 2019 Jan; Vol. 37 (1), pp. 165-172. Date of Electronic Publication: 2018 Jun 07.

Fixation of a complex comminuted proximal femoral fracture in the presence of a Birmingham hip resurfacing prosthesis.

Autor: Aning J; Department of Trauma and Orthopaedics, Cheltenham General Hospital, Cheltenham, Gloucestershire, UK. jonathananing@hotmail.com, Aung H, Mackinnon J

Publikováno v: Injury [Injury] 2005 Sep; Vol. 36 (9), pp. 1127-9.